We demonstrated that CCA cell lines with silencing of ACSL3 expression exhibited markedly increased susceptibility to RSL3 compared to ACSL3-expressing cells, as shown by using the LDH release assay (Fig. 4c, d). Here, ACSL3 is linked to cholangiocarcinoma.